Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naive Patients with MyelofibrosisJohn O. Mascarenhas,Sebastian Grosicki,Dominik Chraniuk,Elisabetta Abruzzese,Prithviraj Bose,Aaron T. Gerds,Alessandro M. Vannucchi,Francesca Palandri,Sung-Eun Lee,Vikas Gupta,Alessandro Lucchesi,Stephen Oh,Andrew T. Kuykendall,Andrea Patriarca,Alberto Alvarez-Larran,Ruben Mesa,Jean-Jacques Kiladjian,Moshe Talpaz, Morgan Harris, Sarah-Katharina Kays, Qing Li, Barbara Brown, Anna-Maria Jegg,Claire Harrison,Raajit RampalBLOOD(2024)引用 0|浏览2AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要